Date
of Report (Date of Earliest Event Reported):
|
|
June
15, 2007
|
Nevada
|
000-50133
|
82-0490737
|
_____________________
(State
or other jurisdiction
|
_____________
(Commission
|
______________
(I.R.S.
Employer
|
of
incorporation)
|
File
Number)
|
Identification
No.)
|
|
|
|
1787
East Ft. Union Blvd., Suite 202
Salt
Lake City, Utah
|
|
84121
|
_________________________________
(Address
of principal executive offices)
|
|
___________
(Zip
Code)
|
|
|
|
Registrant’s
telephone number, including area code:
|
|
(801)
733-0878
|
Item
2.03
|
Creation
of a Direct Financial Obligation or an Obligation Under an Off-Balance
Sheet Arrangement of a
Registrant
|
Exhibit
No.
|
Description
|
10.1
|
Securities
Purchase Agreement dated June 15, 2007 by and among the Company and
New
Millennium Capital Partners II, LLC, AJW Master Fund, Ltd. and AJW
Partners, LLC
|
10.2
|
Form
of Callable Secured Convertible Note dated June 15,
2007
|
10.3
|
Form
of Stock Purchase Warrant dated June 15, 2007
|
10.4
|
Registration
Rights Agreement dated June 15, 2007 by and among the Company and
New
Millennium Capital Partners II, LLC, AJW Master Fund, Ltd. and AJW
Partners, LLC
|
10.5
|
Security
Agreement dated June 15, 2007 by and among the Company and New Millennium
Capital Partners II, LLC, AJW Master Fund, Ltd. and AJW Partners,
LLC
|
10.6
|
Intellectual
Property Security Agreement dated June 15, 2007 by and among the
Company
and New Millennium Capital Partners II, LLC, AJW Master Fund, Ltd.
and AJW
Partners, LLC
|
Grant
Life Sciences, Inc.
|
||
Date:
June 22, 2007
|
By:
|
/s/Doyle
R. Judd
|
Name:
Doyle R. Judd
|
||
Title:
Chief Financial Officer
|